VIROMED MEDICAL AG (VMED.DE) Stock Overview
Europe - FRA:VMED - DE000A3MQR65 - Common Stock
VMED.DE Key Statistics, Chart & Performance
The current stock price of VMED.DE is 3.24 EUR. In the past month the price decreased by -25.68%. In the past year, price increased by 68.37%.
VMED.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABG.DE | CENCORA INC | 21.53 | 55.60B | ||
| AMP.MI | AMPLIFON SPA | 25.84 | 3.39B | ||
| FAGR.BR | FAGRON | 17.42 | 1.51B | ||
| UPR.I | UNIPHAR PLC | 17.36 | 991.56M | ||
| ILM1.DE | MEDIOS AG | 16.54 | 312.24M | ||
| BLC.PA | BASTIDE LE CONFORT MEDICAL | 112.73 | 182.78M |
Related stock screener links
About VMED.DE
Company Profile
Viromed Medical AG engages in the supply and sale of healthcare products for care clinics, general and rehabilitation hospitals, and retirement homes. The company is headquartered in Pinneberg, Schleswig-Holstein. The company went IPO on 2022-05-04. The firm supplies pharma products to clinics, rehabilitation hospitals, nursing homes, medical practitioners, and others. The company conducts research on viruses and bacteria along with developing solutions for medical technology such as cold plasma technology used for wound healing, plasma therapy, and produces medical equipment such as ViroCAP, PulmoPlas, used for curative activities such as in the areas of infection protection, dermatology, and intensive care medicine. Its other products and services include nasal sprays, air purifiers, VitaQuiz, corona tests and others.
Company Info
VIROMED MEDICAL AG
Flensburger Strasse 18
Pinneberg SCHLESWIG-HOLSTEIN DE
Employees: 0
Phone: 494101809960
VIROMED MEDICAL AG / VMED.DE FAQ
Can you describe the business of VIROMED MEDICAL AG?
Viromed Medical AG engages in the supply and sale of healthcare products for care clinics, general and rehabilitation hospitals, and retirement homes. The company is headquartered in Pinneberg, Schleswig-Holstein. The company went IPO on 2022-05-04. The firm supplies pharma products to clinics, rehabilitation hospitals, nursing homes, medical practitioners, and others. The company conducts research on viruses and bacteria along with developing solutions for medical technology such as cold plasma technology used for wound healing, plasma therapy, and produces medical equipment such as ViroCAP, PulmoPlas, used for curative activities such as in the areas of infection protection, dermatology, and intensive care medicine. Its other products and services include nasal sprays, air purifiers, VitaQuiz, corona tests and others.
What is the current price of VMED stock?
The current stock price of VMED.DE is 3.24 EUR. The price decreased by -6.36% in the last trading session.
What is the dividend status of VIROMED MEDICAL AG?
VMED.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of VMED stock?
VMED.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Who owns VIROMED MEDICAL AG?
You can find the ownership structure of VIROMED MEDICAL AG (VMED.DE) on the Ownership tab.
VMED.DE Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to VMED.DE. When comparing the yearly performance of all stocks, VMED.DE is one of the better performing stocks in the market, outperforming 89.56% of all stocks.
VMED.DE Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
VMED.DE Forecast & Estimates
7 analysts have analysed VMED.DE and the average price target is 12.75 EUR. This implies a price increase of 293.52% is expected in the next year compared to the current price of 3.24.